SEIKAGAKU BIOBUSINESS
LIVE

Serial Number

79071476

Owner

SEIKAGAKU CORPORATION

Attorney

Howard N. Aronson

Filing Date

Mar 13, 2009

Add to watchlist:

No watchlists yet
View on USPTO

SEIKAGAKU BIOBUSINESS Trademark

Serial Number: 79071476 • Registration: 4326258

SEIKAGAKU BIOBUSINESS is a trademark filed by SEIKAGAKU CORPORATION on March 13, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

SEIKAGAKU CORPORATION (4 trademarks)

6-1, Marunouchi 1-chome, Chiyoda-ku
Tokyo 100-0005 , JP

Entity Type: 03

Trademark Details

Filing Date

March 13, 2009

Registration Date

April 30, 2013

Published for Opposition

February 12, 2013

Cancellation Date

March 14, 2019

Goods & Services

Laboratory apparatus and instruments for use in performing assays of endotoxin and beta-glucan concentrations, namely, spectrophotometers, test tubes, reaction tubes, assay microplates, pipette tips, 96-well microplates, reagent reservoirs, transfer pipettes, sample containers; Laboratory apparatus and instruments for use in measuring absorbance and turbidity and interpreting the results, namely, density meters, concentration meters; Laboratory apparatus and instruments for use in analyzing urine, namely, clinical laboratory analyzers for measuring, testing and analyzing urine; Laboratory apparatus and instruments, namely, chemical and biochemical analytical instruments in the nature of laboratory chemical reactors, plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Electronic machines, apparatus and their parts, namely, clinical chemistry analyzers for laboratory use in the analysis of biological samples; Magnetic media with recorded programs, namely, pre-recorded magnetic media featuring computer programs used to control and collect data from optical readers, and to analyze data and generate reports for use in the field of endotoxin and beta-glucan analysis

Joint function improving agents, namely, pharmaceutical preparations for treating arthrosis and other joint diseases; ophthalmic surgical aid, namely, sodium hyaluronate solution used for surgery in and around the eyes; Submucosal injection materials for endoscopes used for the treatment of dissecting and resecting tumors and cancer, namely, submucosal injectable preparations for treatment of dissecting and resecting tumors and cancer; Pharmaceutical preparations for the treatment of disc hernia; Syringes sold filled with crosslinked or non-crosslinked hyaluronic acid based gel; Syringes sold filled with sodium hyaluronate solutions; Diagnostic preparations for medical purposes for detecting mycosis; Diagnostic preparations for medical purposes, namely, diagnostic reagents for in-vitro clinical diagnostic purposes

Hyaluronic acid and salts of hyaluronic acid as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chondroitin sulfate and salts of chondoroitin sulfate as raw materials for use in the production of pharmaceutical preparations, cosmetic preparations, food, nutritional supplements and biomaterials, and for research purposes in the biomedical field; Chemical reagents for scientific, research and quality control purposes, namely, limulus amebocyte lysate reagents for use in analysis of endotoxins and beta-glucan; Reagents for scientific medical research and quality control testing use, namely, for use in determining the presence of analytes in or on water, pharmaceutical products, medical devices, dialysate, blood, blood components, body fluids, and tissues; Reagents for clinical or medical laboratory use, namely, glycobiological analysis reagents and diagnostic preparations and reagents for clinical or medical laboratory use

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 4, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Oct 4, 2019 DETH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 30, 2018 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Aug 15, 2014 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 24, 2014 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 9, 2014 FICS
FINAL DISPOSITION PROCESSED
Jan 9, 2014 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 30, 2013 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 30, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Mar 3, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 12, 2013 NPUB
PUBLISHED FOR OPPOSITION
Feb 12, 2013 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 23, 2013 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 23, 2013 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 23, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 9, 2013 PREV
ASSIGNED TO LIE
Jan 4, 2013 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 31, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 15, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 15, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 16, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jun 16, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jun 16, 2012 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 15, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 17, 2011 GNRN
NON-FINAL ACTION E-MAILED
Nov 17, 2011 GNRT
NON-FINAL ACTION WRITTEN
Nov 17, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 1, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2011 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2011 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2011 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 24, 2011 ZZZX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 18, 2011 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 3, 2011 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 3, 2011 OPNR
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jan 21, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 8, 2011 PREV
ASSIGNED TO LIE
Jan 8, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 14, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 9, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 9, 2010 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 9, 2010 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 29, 2010 GNFN
FINAL REFUSAL E-MAILED
Nov 29, 2010 GNFR
FINAL REFUSAL WRITTEN
Nov 29, 2010 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 24, 2010 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 24, 2010 GNRN
NON-FINAL ACTION E-MAILED
Apr 24, 2010 GNRT
NON-FINAL ACTION WRITTEN
Apr 24, 2010 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 16, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 15, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 15, 2010 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 17, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 17, 2010 REAP
REFUSAL PROCESSED BY IB
Oct 10, 2009 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 16, 2009 RFCS
REFUSAL PROCESSED BY MPU
Sep 16, 2009 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 16, 2009 RFCR
NON-FINAL ACTION WRITTEN
Sep 15, 2009 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 12, 2009 MAFR
ASSIGNED TO EXAMINER
Sep 8, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 4, 2009 REPR